Summaries of product characteristics, package leaflets and labelling
The Danish Medicines Agency or the European Commission must authorise medicines before they can be sold in Denmark to guarantee its safety and efficacy. This includes also herbal medicines and strong vitamins and minerals.
Once the products have been authorised, their product information must also be approved. The product information consists of a
- summary of product characteristics (SPC) for healthcare professionals,
- package leaflet for medicine users or those close to them,
- labelling (the product details to be placed on the medicine pack).
Summaries of product characteristics for nationally authorised medicines
The Danish Medicines Agency approves summaries (SPCs) of product characteristics for the medicines it has authorised (nationally) and is also responsible for publishing the SPCs at www.produktresume.dk (the website contains SPCs in Danish only).
Package leaflets for nationally authorised medicines
The pharmaceutical companies are responsible for ensuring that the package leaflets follow the information approved in the summaries of product characteristics. Companies upload their package leaflets to www.indlaegsseddel.dk, which contains the most recent package leaflets (the website contains package leaflets in Danish only).
Product information for medicines authorised in the EU
At www.ema.europa.eu/en/medicines, you can find the product information for medicines authorised by the European Commission via the so-called centralised procedure.
Below we have compiled several guidelines for companies which detail how to write and translate summaries of product characteristics and package leaflets and how the labelling on the packages should be designed. Some information is only available in Danish.
At the bottom, you can find templates for summary of product characteristics, package leaflets and labelling.
Preparation of product information
Translations of product information
Guidance on Nordic packages
The documents 'Guideline on Nordic packages' and 'Questions & Answers' have been prepared in order to facilitate the regulatory work when making common Nordic medicinal packages.
These documents apply to medicinal products for both human and veterinary use. The 'Guideline on Nordic Packages' contains general information on Nordic packages, whereas the 'Questions & Answers' gives detailed advice on different package issues.
Marketing authorisation holders may submit questions regarding issues relating to Nordic packages. For this purpose a specific form, Question to the Nordic package group, should be used. The documents are prepared in cooperation between the medicines agencies in Denmark, Finland, Iceland, Norway, and Sweden.